Search News
| 14.46 Net Asset Value | +0.07% 1 Day | -4.37% Year-to-Date | Overall Morningstar Rating |
| Foreign large value Style or Category | No Load Sales Expenses | 0.83% Expense Ratio | Average Morningstar Risk Rating™ |
| 1 month | -4.11% | 3 years | +1.10% | |
| 3 months | -3.79% | 5 years | +4.18% | |
| 1 year | +1.35% | Since inception | +5.12% |
| TRIGX | Category | |
|---|---|---|
| Performance 5-yr return | +4.18% | +5.52% |
| Expense ratio | 0.83% | 1.17% |
| Risk 5 year sharpe ratio | 0.39 | 0.42 |
| Net assets | $13.0B | $1.6B |
| Average market cap | $24.9B | $32.9B |
| Average P/E | 13.2 | 13.0 |
| Portfolio turnover | 50% | 50% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | T. Rowe Price |
| Fund manager & tenure | Jonathan Matthews / 7 Years |
| Minimal initial investment | $2,500.00 |
| Minimum IRA investment | $1,000.00 |
| International stock | 97.23% |
| Fixed income | 1.44% |
| Cash | 1.33% |
| U.S. stock | 0.00% |
| Other | 0.00% |
| Financial service | 24.22% |
| Industrial materials | 22.65% |
| Consumer goods | 13.81% |
| Telecommunication | 9.81% |
| Energy | 9.40% |
| -- | 2.64% |
| -- | 1.80% |
| -- | 1.76% |
| -- | 1.69% |
| -- | 1.52% |
| -- | 1.50% |
| AZN AstraZeneca | 1.49% |
| VOD Vodafone | 1.45% |
| -- | 1.43% |
| GSK GlaxoSmithKline | 1.40% |
